Tumor Biology

, Volume 33, Issue 4, pp 1237–1243 | Cite as

Association between FTO gene polymorphism and cancer risk: evidence from 16,277 cases and 31,153 controls

  • Guiqiong Li
  • Qingwei Chen
  • Li Wang
  • Dazhi Ke
  • Zhongming Yuan
Research Article

Abstract

A recent genome-wide association study showed that the rs9939609 polymorphism in the fat mass and obesity-associated (FTO) gene was associated with body mass index (BMI)/obesity in Europeans. Subsequently, several studies have investigated the association between FTO polymorphism and cancer risk. However, the results have been inconsistent. In this study, a meta-analysis was performed to clarify the association between FTO polymorphism and cancer risk. Published literature from PubMed and Embase databases were retrieved. Pooled odds ratio (OR) with 95 % confidence interval (CI) was calculated using fixed-effects model. A total of 13 studies involving 16,277 cases and 31,153 controls were identified. The results suggested that FTO rs9939609 polymorphism was not significantly associated with the increased risk of cancer (OR = 1.01, 95 %CI 0.98–1.04), with the exception that a statistically significant association was found for pancreatic cancer (OR = 1.10, 95 %CI 1.03–1.19). No publication bias was detected (Begg’s test: P = 0.760; Egger’s test: P = 0.553). Our meta-analysis indicated that there was no association between FTO rs9939609 polymorphism and the increased risk of cancer, although this polymorphism was marginally associated with pancreatic cancer. However, the conclusion should be made with caution since most included studies did not take BMI/obesity into account.

Keywords

Cancer FTO Polymorphism Meta-analysis 

References

  1. 1.
    Wang D, Zheng W, Wang SM, Wang JB, Wei WQ, Liang H, et al. Estimation of cancer incidence and mortality attributable to overweight, obesity, and physical inactivity in China. Nutr Cancer. 2012;64:48–56.PubMedCrossRefGoogle Scholar
  2. 2.
    Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316:889–94.PubMedCrossRefGoogle Scholar
  3. 3.
    Xi B. Mi J.FTO polymorphisms are associated with obesity but not with diabetes in East Asian populations: a meta-analysis. Biomed Environ Sci. 2009;22:449–57.PubMedCrossRefGoogle Scholar
  4. 4.
    Adeyemo A, Chen G, Zhou J, Shriner D, Doumatey A, Huang H, et al. FTO genetic variation and association with obesity in West Africans and African Americans. Diabetes. 2010;59:1549–54.PubMedCrossRefGoogle Scholar
  5. 5.
    Wang H, Dong S, Xu H, Qian J, Yang J. Genetic variants in FTO associated with metabolic syndrome: a meta- and gene-based analysis. Mol Biol Rep. 2011. doi:10.1007/s11033-011-1377-y.
  6. 6.
    Cecil JE, Tavendale R, Watt P, Hetherington MM, Palmer CN. An obesity-associated FTO gene variant and increased energy intake in children. N Engl J Med. 2008;359:2558–66.PubMedCrossRefGoogle Scholar
  7. 7.
    Kaklamani V, Yi N, Sadim M, Siziopikou K, Zhang K, Xu Y, et al. The role of the fat mass and obesity associated gene (FTO) in breast cancer risk. BMC Med Genet. 2011;12:52.PubMedCrossRefGoogle Scholar
  8. 8.
    Kusinska R, Górniak P, Pastorczak A, Fendler W, Potemski P, Mlynarski W, et al. Influence of genomic variation in FTO at 16q12.2, MC4R at 18q22 and NRXN3 at 14q31 genes on breast cancer risk. Mol Biol Rep. 2012;39:2915–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Lurie G, Gaudet MM, Spurdle AB, Carney ME, Wilkens LR, Yang HP, et al. The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic White women. PLoS One. 2011;6:e16756.PubMedCrossRefGoogle Scholar
  10. 10.
    Delahanty RJ, Beeghly-Fadiel A, Xiang YB, Long J, Cai Q, Wen W, et al. Association of obesity-related genetic variants with endometrial cancer risk: a report from the Shanghai Endometrial Cancer Genetics Study. Am J Epidemiol. 2011;174:1115–26.PubMedCrossRefGoogle Scholar
  11. 11.
    Gaudet MM, Yang HP, Bosquet JG, Healey CS, Ahmed S, Dunning AM, et al. No association between FTO or HHEX and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev. 2010;19:2106–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Tang H, Dong X, Hassan M, Abbruzzese JL, Li D. Body mass index and obesity- and diabetes-associated genotypes and risk for pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2011;20:779–92.PubMedCrossRefGoogle Scholar
  13. 13.
    Pierce BL, Austin MA, Ahsan H. Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data. Cancer Causes Control. 2011;22:877–83.PubMedCrossRefGoogle Scholar
  14. 14.
    Meyer TE, Boerwinkle E, Morrison AC, Volcik KA, Sanderson M, Coker AL, et al. Diabetes genes and prostate cancer in the atherosclerosis risk in communities study. Cancer Epidemiol Biomarkers Prev. 2010;19:558–65.PubMedCrossRefGoogle Scholar
  15. 15.
    Lewis SJ, Murad A, Chen L. Davey Smith G, Donovan J, Palmer T, et al. Associations between an obesity related genetic variant (FTO rs9939609) and prostate cancer risk. PLoS One. 2010;5:e13485.PubMedCrossRefGoogle Scholar
  16. 16.
    Tarabra E, Actis GC, Fadda M, De Paolis P, Comandone A, Coda R, et al. The obesity gene and colorectal cancer risk: a population study in Northern Italy. Eur J Intern Med. 2012;23:65–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Brennan P, McKay J, Moore L, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, et al. Obesity and cancer: Mendelian randomization approach utilizing the FTO genotype. Int J Epidemiol. 2009;38:971–5.PubMedCrossRefGoogle Scholar
  18. 18.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.PubMedCrossRefGoogle Scholar
  19. 19.
    Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMedGoogle Scholar
  20. 20.
    Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.PubMedCrossRefGoogle Scholar
  21. 21.
    Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.PubMedCrossRefGoogle Scholar
  22. 22.
    Nock NL, Plummer SJ, Thompson CL, Casey G, Li L. FTO polymorphisms are associated with adult body mass index (BMI) and colorectal adenomas in African-Americans. Carcinogenesis. 2011;32:748–56.PubMedCrossRefGoogle Scholar
  23. 23.
    Fischer J, Koch L, Emmerling C, Vierkotten J, Peters T, Brüning JC, et al. Inactivation of the FTO gene protects from obesity. Nature. 2009;458:894–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Zimmermann E, Kring SI, Berentzen TL, Holst C, Pers TH, Hansen T, et al. Fatness-associated FTO gene variant increases mortality independent of fatness—in cohorts of Danish men. PLoS One. 2009;4:e4428.PubMedCrossRefGoogle Scholar
  25. 25.
    Stratigopoulos G, Padilla SL, LeDuc CA, Watson E, Hattersley AT, McCarthy MI, et al. Regulation of Fto/Ftm gene expression in mice and humans. Am J Physiol Regul Integr Comp Physiol. 2008;294:R1185–96.PubMedCrossRefGoogle Scholar
  26. 26.
    Jowett JB, Curran JE, Johnson MP, Carless MA, Göring HH, Dyer TD, et al. Genetic variation at the FTO locus influences RBL2 gene expression. Diabetes. 2010;59:726–32.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2012

Authors and Affiliations

  • Guiqiong Li
    • 1
  • Qingwei Chen
    • 1
  • Li Wang
    • 1
  • Dazhi Ke
    • 1
  • Zhongming Yuan
    • 1
  1. 1.Department of Geriatrics CardiologyThe Second Affiliated Hospital of Chongqing Medical UniversityChongqingChina

Personalised recommendations